Oncogenes induce a vimentin filament collapse mediated by HDAC6 that is linked to cell stiffness

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 4, 2014, Pages 1515-1520

  Rathje, Li Sophie Z ^a   Nordgren, Niklas ^b,d   Pettersson, Torbjörn ^b   Rönnlund, Daniel ^c   Widengren, Jerker ^c   Aspenström, Pontus ^a   Gad, Annica K B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c ALBANOVA UNIVERSITY CENTER   (Sweden)

^d SP TECHNICAL RESEARCH INSTITUTE OF SWEDEN   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; HISTONE DEACETYLASE 6; MYC PROTEIN; VIMENTIN; VIRUS LARGE T ANTIGEN;

ARTICLE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; GENE EXPRESSION; INTERMEDIATE FILAMENT; MICROTUBULE; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; RIGIDITY; SIMIAN VIRUS 40; TUMOR CELL; TUMOR INVASION;

CELL INVASION; CELL MECHANICS; COLLOIDAL PROBE FORCE-MODE ATOMIC FORCE MICROSCOPY; CYTOSKELETON; STED MICROSCOPY;

ACETYLATION; CELL LINE; CELL MOVEMENT; HISTONE DEACETYLASES; HUMANS; MICROTUBULES; ONCOGENES; VIMENTIN;

EID: 84893371702     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1300238111     Document Type: Article

References (47)

1. Campbell PM, et al. (2007) K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res 67(5):2098-2106.
2. Makrodouli E, et al. (2011) BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: A comparative study. Mol Cancer 10:118.
3. Ostad M, Weiss R, Droller M, Liu B (1992) Ha-ras oncogene induction of invasion and metastasis is associated with the activation and redistribution of protease(s) in ratkidney cells. Int J Oncol 1(7):765-771.
4. Egeblad M, Rasch MG, Weaver VM (2010) Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22(5):697-706.
5. Bhadriraju K, Hansen LK (2002) Extracellular matrix- and cytoskeleton-dependent changes in cell shape and stiffness. Exp Cell Res 278(1):92-100.
6. Wakatsuki T, Schwab B, Thompson NC, Elson EL (2001) Effects of cytochalasin D and latrunculin B on mechanical properties of cells. J Cell Sci 114(Pt 5):1025-1036.
7. Gilles C, et al. (1999) Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112(Pt 24):4615-4625.
8. Mendez MG, Kojima S, Goldman RD (2010) Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J 24(6): 1838-1851.
9. Satelli A, Li S (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68(18):3033-3046.
10. Vuoriluoto K, et al. (2011) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30(12): 1436-1448.
11. Suresh S (2007) Biomechanics and biophysics of cancer cells. Acta Biomater 3(4): 413-438.
12. Herrmann H, Strelkov SV, Burkhard P, Aebi U (2009) Intermediate filaments: Primary determinants of cell architecture and plasticity. J Clin Invest 119(7):1772-1783.
13. Wagner OI, et al. (2007) Softness, strength and self-repair in intermediate filament networks. Exp Cell Res 313(10):2228-2235.
14. Eckes B, et al. (1998) Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci 111(Pt 13):1897-1907.
15. Guo M, et al. (2013) The role of vimentin intermediate filaments in cortical and cytoplasmic mechanics. Biophys J 105(7):1562-1568.
16. Ahuja D, Sáenz-Robles MT, Pipas JM (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24(52):7729-7745.
17. Albihn A, Johnsen JI, Henriksson MA (2010) MYC in oncogenesis and as a target for cancer therapies. Adv Cancer Res 107:163-224.
18. Schraml P, et al. (2003) Cyclin E overexpression and amplification in human tumours. J Pathol 200(3):375-382.
19. Aldana-Masangkay GI, Sakamoto KM (2011) The role of HDAC6 in cancer. J Biomed Biotechnol 2011:875824.
20. Lee YS, et al. (2008) The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Res 68(18):7561-7569.
21. Hubbert C, et al. (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417(6887):455-458.
22. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL (2003) Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 100(8):4389-4394.
23. Saji S, et al. (2005) Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene 24(28): 4531-4539.
24. Dallavalle S, Pisano C, Zunino F (2012) Development and therapeutic impact of HDAC6-selective inhibitors. Biochem Pharmacol 84(6):756-765.
25. Danielsson F, et al. (2013) Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model. Proc Natl Acad Sci USA 110(17):6853-6858.
26. Rönnlund D, Gad AK, Blom H, Aspenström P,Widengren J (2013) Spatial organization of proteins in metastasizing cells. Cytometry A 83(9):855-865.
27. Valgeirsdóttir S, et al. (1998) PDGF induces reorganization of vimentin filaments. J Cell Sci 111(Pt 14):1973-1980.
28. Prahlad V, Yoon M, Moir RD, Vale RD, Goldman RD (1998) Rapid movements of vimentin on microtubule tracks: Kinesin-dependent assembly of intermediate filament networks. J Cell Biol 143(1):159-170.
29. Goldman RD (1971) The role of three cytoplasmic fibers in BHK-21 cell motility. I. Microtubules and the effects of colchicine. J Cell Biol 51(3):752-762.
30. Bershadsky AD, Vaisberg EA, Vasiliev JM (1991) Pseudopodial activity at the active edge of migrating fibroblast is decreased after drug-induced microtubule depolymerization. Cell Motil Cytoskeleton 19(3):152-158.
31. Reed NA, et al. (2006) Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 16(21):2166-2172.
32. Maruta H, Greer K, Rosenbaum JL (1986) The acetylation of alpha-tubulin and its relationship to the assembly and disassembly of microtubules. J Cell Biol 103(2): 571-579.
33. Loktev AV, et al. (2008) A BBSome subunit links ciliogenesis, microtubule stability, and acetylation. Dev Cell 15(6):854-865.
34. Zhang Y, et al. (2003) HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J 22(5):1168-1179.
35. Zilberman Y, et al. (2009) Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci 122(Pt 19):3531-3541.
36. Choudhary C, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325(5942):834-840.
37. Kreplak L, Bär H, Leterrier JF, Herrmann H, Aebi U (2005) Exploring the mechanical behavior of single intermediate filaments. J Mol Biol 354(3):569-577.
38. Bär H, et al. (2006) Forced expression of desmin and desmin mutants in cultured cells: Impact of myopathic missense mutations in the central coiled-coil domain on network formation. Exp Cell Res 312(9):1554-1565.
39. Plodinec M, et al. (2011) The nanomechanical properties of rat fibroblasts are modulated by interfering with the vimentin intermediate filament system. J Struct Biol 174(3):476-484.
40. Bastatas L, et al. (2012) AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential. Biochim Biophys Acta 1820(7):1111-1120.
41. Cross SE, et al. (2008) AFM-based analysis of human metastatic cancer cells. Nanotechnology 19(38):384003.
42. Ochalek T, Nordt FJ, Tullberg K, Burger MM (1988) Correlation between cell deformability and metastatic potential in B16-F1 melanoma cell variants. Cancer Res 48(18):5124-5128.
43. Remmerbach TW, et al. (2009) Oral cancer diagnosis by mechanical phenotyping. Cancer Res 69(5):1728-1732.
44. Ward KA, Li WI, Zimmer S, Davis T (1991) Viscoelastic properties of transformed cells: Role in tumor cell progression and metastasis formation. Biorheology 28(3-4): 301-313.
45. Coughlin MF, et al. (2013) Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential. Clin Exp Metastasis 30(3):237-250.
46. Lamb NJ, Fernandez A, Feramisco JR, Welch WJ (1989) Modulation of vimentin containing intermediate filament distribution and phosphorylation in living fibroblasts by the cAMP-dependent protein kinase. J Cell Biol 108(6):2409-2422.
47. Helfand BT, et al. (2011) Vimentin organization modulates the formation of lamellipodia. Mol Biol Cell 22(8):1274-1289.